Gleevec is the first-line therapy for everyone with CML.
Hydrea is used temporarily to reduce the white blood cell
count if it is very high at diagnosis.Stem cell
tansplantation is considered in patients whose disease comes back after initial treatment with imatinib (Gleevec). Long-term cure after transplantation
ranges from 60 - 80%.
consult your oncologist
about it and further action